Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Roche presents new CCR3 receptor antagonists and their use in asthma therapy

April 15, 2003

Discovery's lung surfactant shows significant antiinflammatory properties

April 11, 2003

Potent CCR3 receptor antagonists with potential in chronic inflammation

April 8, 2003

Preclinical evaluation of rhATIII for treatment of acute lung injury

April 4, 2003

NCX-1020 enters clinical development

April 3, 2003

Dual CCR3 modulators/H1 antagonists and their use reported by AstraZeneca

April 3, 2003

DCF-987 constituent awarded orphan drug status for cystic fibrosis

April 2, 2003

PDE4 inhibitors described by Merck Frosst for asthma and other uses

April 2, 2003

FDA advisory committee sets May date for review of Xolair BLA

April 1, 2003

DCF-987 phase II trial on track

March 31, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 7, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...